BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24550552)

  • 1. Future of implantable devices for cardiac rhythm management.
    Lau CP; Siu CW; Tse HF
    Circulation; 2014 Feb; 129(7):811-22. PubMed ID: 24550552
    [No Abstract]   [Full Text] [Related]  

  • 2. The implantable cardioverter-defibrillator minimalist: an approach to patient follow-up and management of implantable defibrillators.
    Sweeney MO
    Circulation; 2012 Jul; 126(3):369-77. PubMed ID: 22801654
    [No Abstract]   [Full Text] [Related]  

  • 3. New frontiers in cardiac devices.
    Dennis AS; Behar JM
    Br J Hosp Med (Lond); 2020 Oct; 81(10):92-103. PubMed ID: 33135932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Implantable Electronic Device Therapy: Permanent Pacemakers, Implantable Cardioverter Defibrillators, and Cardiac Resynchronization Devices.
    Steffen MM; Osborn JS; Cutler MJ
    Med Clin North Am; 2019 Sep; 103(5):931-943. PubMed ID: 31378335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The progress of electrical treatment of arrhythmia].
    Fang ZX
    Zhongguo Yi Liao Qi Xie Za Zhi; 2002 Jan; 26(1):3-6. PubMed ID: 16104147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present guidelines for device implantation: clinical considerations and clinical challenges from pacing, implantable cardiac defibrillator, and cardiac resynchronization therapy.
    Poole JE
    Circulation; 2014 Jan; 129(3):383-94. PubMed ID: 24446408
    [No Abstract]   [Full Text] [Related]  

  • 7. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.
    Raatikainen MJ; Arnar DO; Merkely B; Camm AJ; Hindricks G
    Europace; 2016 Aug; 18 Suppl 3():iii1-iii79. PubMed ID: 27496955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of remote magnetic catheter navigation and ablation with implanted devices for pacing and defibrillation.
    Lüthje L; Vollmann D; Seegers J; Sohns C; Hasenfuss G; Zabel M
    Europace; 2010 Nov; 12(11):1574-80. PubMed ID: 20810533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New technologies of internal defibrillation.
    Dosdall DJ; Ideker RE
    J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():67-70. PubMed ID: 16133858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How are arrhythmias detected by implanted cardiac devices managed in Europe? Results of the European Heart Rhythm Association Survey.
    Todd D; Hernandez-Madrid A; Proclemer A; Bongiorni MG; Estner H; Blomström-Lundqvist C;
    Europace; 2015 Sep; 17(9):1449-53. PubMed ID: 26443791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring an unstable heart. Implantable cardioverter-defibrillators.
    Mayo Clin Health Lett; 2006 Jun; 24(6):1-3. PubMed ID: 16830395
    [No Abstract]   [Full Text] [Related]  

  • 12. The Year in Cardiology 2013: arrhythmias.
    Heinz Kuck K; Hindricks G
    Eur Heart J; 2014 Feb; 35(8):485-90. PubMed ID: 24385372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OptiVol fluid index: does an association with ventricular arrhythmias hold water?
    Sullivan RM; Olshansky B
    J Cardiovasc Electrophysiol; 2011 Mar; 22(3):300-1. PubMed ID: 21091968
    [No Abstract]   [Full Text] [Related]  

  • 14. Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure.
    Sengupta J; Abdelhadi R
    Curr Opin Cardiol; 2013 May; 28(3):337-43. PubMed ID: 23549236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the use of implantable cardioverter defibrillators. A Task Force of the Working Groups on Cardiac Arrhythmias and Cardiac Pacing of the European Society of Cardiology.
    Eur Heart J; 1992 Oct; 13(10):1304-10. PubMed ID: 1396800
    [No Abstract]   [Full Text] [Related]  

  • 16. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
    Samii SM
    Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias.
    Saksena S; Prakash A; Madan N; Giorgberidze I; Munsif AN; Mathew P; Kaushik R; Krol RB
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():149-54. PubMed ID: 8734177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.
    van Veldhuisen DJ; Maass AH; Priori SG; Stolt P; van Gelder IC; Dickstein K; Swedberg K
    Eur J Heart Fail; 2009 Dec; 11(12):1143-51. PubMed ID: 19884129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The year in cardiology 2014: arrhythmias and device therapy.
    Heidbuchel H; Hindricks G
    Eur Heart J; 2015 Feb; 36(5):270-8. PubMed ID: 25559132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Device therapy after acute coronary syndrome].
    Przibille O; Himmrich E; Andreas K; Nowak B
    Dtsch Med Wochenschr; 2014 Jan; 139 Suppl 1():S36-9. PubMed ID: 24446042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.